硼替佐米与多发性骨髓瘤的髓外疾病：月亮的光明面与黑暗面 - Suppr

Suppr

超能文献

Bortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moon.

作者信息

Ali Ridvan, Ozkalemkas Fahir, Ozkan Atilla, Ozkocaman Vildan, Ozcelik Tulay, Ozan Ulku, Kurt Meral, Tunali Ahmet

出版信息

Leuk Res. 2007 Aug;31(8):1153-5. doi: 10.1016/j.leukres.2006.07.017. Epub 2006 Sep 1.

DOI:10.1016/j.leukres.2006.07.017

PMID:16945413

Abstract

摘要

相似文献

Bortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moon.

Leuk Res. 2007 Aug;31(8):1153-5. doi: 10.1016/j.leukres.2006.07.017. Epub 2006 Sep 1.

Side effects and good effects from new chemotherapeutic agents. Case 3. Bortezomib in primary refractory plasmacytoma.

J Clin Oncol. 2005 Apr 1;23(10):2426-8. doi: 10.1200/JCO.2005.04.079.

Bortezomib data show improved survival in patients with relapsed multiple myeloma.

Oncology (Williston Park). 2004 Aug;18(9):1199, 1201.

Optimizing bortezomib treatment in patients with relapsed multiple myeloma.

Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 8; suppl 13.

Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma.

Haematologica. 2008 Jun;93(6):953-4. doi: 10.3324/haematol.12522.

Bortezomib therapy following first relapse.

Oncology (Williston Park). 2005 Jan;19(1):23-6.

Sustained remission including marked regression of a paravertebral plasmacytoma in a patient with heavily pretreated, relapsed multiple myeloma after treatment with bortezomib.

Leuk Res. 2005 Dec;29(12):1473-7. doi: 10.1016/j.leukres.2005.05.003. Epub 2005 Jun 16.

Inefficacy of bortezomib therapy for CNS involvement of refractory multiple myeloma.

Leuk Res. 2007 May;31(5):721-3. doi: 10.1016/j.leukres.2006.06.019. Epub 2006 Aug 4.

Bortezomib increases survival of patients with relapsed multiple myeloma.

Health News. 2005 Sep;11(9):9.

Effects of bortezomib on bone disease in multiple myeloma.

Am J Hematol. 2009 Jan;84(1):1-2. doi: 10.1002/ajh.21324.

引用本文的文献

Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review.

Case Rep Hematol. 2020 Jan 3;2020:8563098. doi: 10.1155/2020/8563098. eCollection 2020.

Extramedullary multiple myeloma.

Leukemia. 2020 Jan;34(1):1-20. doi: 10.1038/s41375-019-0660-0. Epub 2019 Nov 27.

Dysphagia as an Unusual Presentation of Myeloma.

Case Rep Hematol. 2018 Dec 13;2018:6910624. doi: 10.1155/2018/6910624. eCollection 2018.

Large Plasmacytoma Occupying the Upper Limb in a Myeloma Patient.

Rare Tumors. 2017 Mar 30;9(1):5866. doi: 10.4081/rt.2017.5866. eCollection 2017 Mar 24.

Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance.

Onco Targets Ther. 2012;5:329-34. doi: 10.2147/OTT.S35348. Epub 2012 Nov 7.

Imaging features of extramedullary, relapsed, and refractory multiple myeloma involving the liver across treatment with cyclophosphamide, lenalidomide, bortezomib, and dexamethasone.

J Clin Oncol. 2012 Jul 10;30(20):e175-9. doi: 10.1200/JCO.2011.41.1413. Epub 2012 Jun 11.

A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment.

Case Rep Oncol. 2011 Feb 25;4(1):101-5. doi: 10.1159/000324920.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验